Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Ocean Biomedical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Ocean Biomedical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kathuria Chirinjeev | Director, 10% Owner | 22,342,756Indirect | Oct 6, 2023 | 0 |
| Poseidon Bio, LLC | 10% Owner | 22,342,756Indirect | Oct 6, 2023 | 0 |
| Ajjarapu Surendra K | Director, 10% Owner | 21,252Indirect | Mar 24, 2023 | 0 |
| Aesther Healthcare Sponsor, LLC | 10% Owner | 21,252Indirect | Mar 24, 2023 | 0 |
| Peterson Michael L | Director | 80,000 | Mar 2, 2023 | 0 |
| Owens William F | Director | – | Feb 17, 2023 | 0 |
| Berrey M Michelle | Director | – | Feb 17, 2023 | 0 |
| Ringo Jerome | Director | – | Feb 17, 2023 | 0 |
| Kurtis Jonathan | Director | – | Feb 17, 2023 | 0 |
| Angle Martin D | Director | – | Feb 17, 2023 | 0 |
| Elias Jack A | Director | – | Feb 17, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.